van Winden, Tijn M. S.
Nijman, Tobias A. J.
Kleinrouweler, C. Emily
Salim, Raed
Kashanian, Maryam
Al-Omari, Wafa R.
Pajkrt, Eva
Mol, Ben W.
Oudijk, Martijn A.
Roos, Carolien
Funding for this research was provided by:
ZonMw (843002826)
National Health and Medical Research Council (GNT1176437)
Merck
Article History
Received: 28 February 2022
Accepted: 29 April 2022
First Online: 15 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: Ben W. Mol is supported by a NHMRC Investigator grant (GNT1176437) and reports consultancy for Merck. Eva Pajkrt reports a grant from ZonMW (PPROMEXIL follow-up study). The other authors declare that they have no competing interests.